These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 21365809)
1. [Emergency thrombolysis in ischemic stroke disseminated over the country. There are still marked regional variations according to Riks-Stroke analysis]. Eriksson M; Jonsson F; Appelros P; Asberg KH; Norrving B; Stegmayr B; Terént A; Asplund K Lakartidningen; 2011 Jan 12-18; 108(1-2):21-5. PubMed ID: 21365809 [No Abstract] [Full Text] [Related]
2. [Can the target group for thrombolysis in acute ischemic stroke be widened? Current indication is very narrow--new study results are necessary]. Murray V Lakartidningen; 2011 Jan 12-18; 108(1-2):16-7. PubMed ID: 21365808 [No Abstract] [Full Text] [Related]
3. [Brazilian consensus for the thrombolysis in acute ischemic stroke]. Sociedade Brasileira de Doenças Cerebrovasculares (SBDCV) Arq Neuropsiquiatr; 2002 Sep; 60(3-A):675-80. PubMed ID: 12244414 [TBL] [Abstract][Full Text] [Related]
4. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke. Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405 [TBL] [Abstract][Full Text] [Related]
5. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry. Kobayashi A; Czlonkowska A; Ahmed N; Romanowicz S; Glonek M; Nyka WM; Opala G; Wahlgren N; Acta Neurol Scand; 2010 Oct; 122(4):229-36. PubMed ID: 19919643 [TBL] [Abstract][Full Text] [Related]
6. Why are eligible thrombolysis candidates left untreated? Hills NK; Johnston SC Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305 [TBL] [Abstract][Full Text] [Related]
7. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. California Acute Stroke Pilot Registry (CASPR) Investigators Neurology; 2005 Feb; 64(4):654-9. PubMed ID: 15728287 [TBL] [Abstract][Full Text] [Related]
8. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152 [TBL] [Abstract][Full Text] [Related]
10. [Thrombolytic therapy in stroke approved with reservation. Underlying evidence, practical guidelines and safety follow up]. Wahlgren NG Lakartidningen; 2004 Feb; 101(8):674-7. PubMed ID: 15024940 [No Abstract] [Full Text] [Related]
11. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan. Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704 [TBL] [Abstract][Full Text] [Related]